Clinical Trial Update: Rivastigmine Capsules in Patients With Probable Vascular Dementia [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating rivastigmine capsules for probable vascular dementia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vascular Dementia

Drugs mentioned

• Rivastigmine capsules (rivastigmine)

Snippet

Sponsor: Novartis | Conditions: Vascular Dementia | Phase 3 | Status: COMPLETED